A small pilot study in nondiabetic subjects at cardiovascular risk found that one gram of ALCAR twice daily for 24 weeks improved glucose disposal rates in those who were most insulin-resistant at baseline
In animal embyrofetal development studies of oral ivermectin given during organogenesis, adverse developmental outcomes, including cleft palate, exencephaly, wavy ribs, and clubbed forepaws, occurred at or near doses that were maternally toxic
Antioxidant activation: GHK-Cu upregulates superoxide dismutase and other antioxidant enzymes, reducing oxidative damage from sun, pollution, and cellular aging
Verywell Health Key takeaways ADA 2025 supports CGM broadly, with expanded consideration for adults with type 2 diabetes beyond insulin
Frequently Asked Questions about NMN, TMG, and GlyNAC What is the difference between NMN and GlyNAC
And without research into these specific formulations, its impossible to predict effectiveness